Compared to benign luminal epithelial cells, cancer cells in all clusters (5, 6, and 11) were enriched for potential therapeutic targets and/or biomarkers, including FOLH1 (PSMA)40–42 and PCA343,44 (Fig. 3b). The gene discussed is FOLH1; the disease is cancer.